Trinity Biotech Premier Hb9210™ HbA1c System - HSA Registration DE0502178
Access comprehensive regulatory information for Trinity Biotech Premier Hb9210™ HbA1c System in the Singapore medical device market through Pure Global AI's free database. This CLASS B IVD medical device is registered under HSA registration number DE0502178 and owned by Trinity Biotech plc. The device was registered on September 20, 2018.
This page provides complete registration details including product owner information, registrant details, importer information, and regulatory compliance data from the official Singapore HSA medical device database. Pure Global AI offers free access to Singapore's complete medical device registry, helping global MedTech companies navigate HSA regulations efficiently.
The Premier Hb9210™ system is intended for the quantitative measurement of hemoglobin A1c (HbA1c) in human capillary and venous whole blood. It is indicated for the monitoring of long-term glycemic control in individuals with diabetes mellitus. For in vitro diagnostic use only.

